← Back

Wire · opportunities

Abbott update allows heart readings to be seen at home

Published

6 October 2026

Topic

opportunities

◆ Sectors

Medtech

◆ Geography

United States

◆ Source

Read at fiercebiotech.com →

◆ Verified

Fusion42 · 7 October 2026 · Fusion42 review

Abbott received FDA clearance for updates to its CardioMEMS HF System, enabling heart failure patients in the U.S. to view pulmonary artery pressure readings on their smartphones and receive personalised medication adjustment plans through the CardioGuide HF App.

This Wire brief sits within Fusion42's coverage of Medtech, and 5 sources have reported it between 5 Oct 2026 and 8 Oct 2026.

◆ ◆ The Wire takeaway

You can now build on the open door for direct-to-patient heart monitoring apps that integrate with implantable sensor data. Abbott’s move signals a market opening for mobile health tools that connect clinicians and patients in heart failure care.

◆ Coverage

5 sources · first reported 5 Oct 2026 · latest 8 Oct 2026

◆ Related on Wire

◆ Topics

Medtechmedtechheart-failuredigital-healthFDA-approvalpatient-monitoringmobile-health